
1. antimicrob agents chemother. 2014;58(1):342-7. doi: 10.1128/aac.02279-12. epub
2013 oct 28.

plasmodium vivax chloroquine resistance anemia western brazilian
amazon.

marques mm(1), costa mr, santana filho fs, vieira jl, nascimento mt, brasil lw,
nogueira f, silveira h, reyes-lecca rc, monteiro wm, lacerda mv, alecrim mg.

author information: 
(1)fundação de medicina tropical dr. heitor vieira dourado, manaus, brazil.

data chloroquine (cq)-resistant plasmodium vivax latin america limited, 
even current research efforts sustain efficient malaria control
program countries p. vivax endemic malaria still 
is major public health issue. study estimated vivo cq resistance in
patients uncomplicated p. vivax malaria, use cq primaquine
simultaneously, brazilian amazon. total 135 enrolled subjects 
accomplished 28-day follow-up, parasitological failure observed 7
(5.2%) patients, plasma cq desethylchloroquine (dcq) concentrations
were 100 ng/dl. univariate analysis showed previous exposure to
malaria higher initial mean parasitemia associated resistance but
not age gender. multivariate analysis, high initial
parasitemia remained significant. hemoglobin levels similar beginning
of follow-up associated parasitemia. however, day 3 
day 7, hemoglobin levels significantly lower patients presenting cq
resistance. p. vivax dhfr (pvdhfr), pvmrp1, pvmdr1, pvdhps gene mutations
were related resistance small sample. p. vivax cq resistance is
already problem brazilian amazon, could extent
associated simultaneous report anemia triggered parasite, a
common complication disease areas endemicity.

doi: 10.1128/aac.02279-12 
pmcid: pmc3910749
pmid: 24165179  [indexed medline]

